|Bid||1.0700 x 21500|
|Ask||1.0800 x 2900|
|Day's range||1.0600 - 1.1000|
|52-week range||0.7300 - 5.4300|
|Beta (5Y monthly)||0.96|
|PE ratio (TTM)||N/A|
|Earnings date||22 Feb 2023 - 27 Feb 2023|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||09 Nov 2012|
|1y target est||7.75|
Profound Medical (PROF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Vaxart ( NASDAQ:VXRT ) Third Quarter 2022 Results Key Financial Results Net loss: US$29.3m (loss widened by 67% from 3Q...
VAXART, INC. (VXRT) delivered earnings and revenue surprises of 4.17% and 100%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?